1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Thrombosis Global Clinical Trials Review, H2, 2014

Thrombosis Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • GlobalData
  • -
  • 154 pages

Thrombosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Thrombosis Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Thrombosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Thrombosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Thrombosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Thrombosis 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Thrombosis Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
C. H. Boehringer Sohn AG and Co. KG 38
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 38
Bayer AG 44
Clinical Trial Overview of Bayer AG 44
Sanofi 48
Clinical Trial Overview of Sanofi 48
GlaxoSmithKline plc 51
Clinical Trial Overview of GlaxoSmithKline plc 51
Pfizer Inc. 54
Clinical Trial Overview of Pfizer Inc. 54
AstraZeneca PLC 56
Clinical Trial Overview of AstraZeneca PLC 56
Bristol-Myers Squibb Company 59
Clinical Trial Overview of Bristol-Myers Squibb Company 59
Daiichi Sankyo Company, Limited 61
Clinical Trial Overview of Daiichi Sankyo Company, Limited 61
Astellas Pharma Inc. 63
Clinical Trial Overview of Astellas Pharma Inc. 63
The LEO Foundation 65
Clinical Trial Overview of The LEO Foundation 65
Clinical Trial Overview of Top Institutes / Government 66
National Heart, Lung, and Blood Institute 66
Clinical Trial Overview of National Heart, Lung, and Blood Institute 66
Hamilton Health Sciences 67
Clinical Trial Overview of Hamilton Health Sciences 67
Brigham and Women's Hospital 68
Clinical Trial Overview of Brigham and Women's Hospital 68
Ottawa Hospital Research Institute 69
Clinical Trial Overview of Ottawa Hospital Research Institute 69
Assistance Publique - Hopitaux de Paris 70
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 70
McMaster University 71
Clinical Trial Overview of McMaster University 71
Seoul National University Hospital 72
Clinical Trial Overview of Seoul National University Hospital 72
Academic Medical Center 73
Clinical Trial Overview of Academic Medical Center 73
Medical University of Vienna 74
Clinical Trial Overview of Medical University of Vienna 74
Beijing Chao-Yang Hospital 75
Clinical Trial Overview of Beijing Chao-Yang Hospital 75
Five Key Clinical Profiles 76
Appendix 152
Abbreviations 152
Definitions 152
Research Methodology 153
Secondary Research 153
About GlobalData 154
Contact Us 154
Disclaimer 154
Source 154

List of Tables
Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Thrombosis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Thrombosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 38
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 44
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 48
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 51
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 54
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 56
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 59
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 61
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 63
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2014* 65
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 66
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 67
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 68
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 69
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 70
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2014* 71
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 72
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 73
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 74
Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao-Yang Hospital, 2014* 75

List of Figures
Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 153

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hemophilia Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Hemophilia Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Hemophilia Treatment Drugs Market: Overview Hemophilia is a rare blood disorder. Hemophilia is a combination of two Greek words that is haima (blood) and philia (affection). Hemophilia is a hereditary ...

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...

Epiomic Epidemiology Series: Polycythemia Vera Forecast in 27 Major Markets 2016-2026

Epiomic Epidemiology Series: Polycythemia Vera Forecast in 27 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • December 2016
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Polycythemia Vera in 27 Major Markets Polycythemia Vera (PV), also known as erythraemia, erythrocytosis, erythrocytosis megalosplenica, ...


Download Unlimited Documents from Trusted Public Sources

Blood Disease and HIV AIDS Statistics in Africa and Malawi

  • March 2017
    22 pages
  • Blood Disease  

    HIV AIDS  

    Infectious Dise...  

  • Africa  

    Malawi  

View report >

Blood Disease Statistics in the US - Forecast

  • March 2017
    10 pages
  • Blood Disease  

    Compression The...  

    Cardiovascular ...  

  • United States  

View report >

Blood Disease Statistics in the US

  • March 2017
    5 pages
  • Blood Disease  

    Pumpkin  

  • United States  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.